{"id":"W2515900781","doi":"10.1016/s2213-2600(16)30265-x","title":"Efficacy and safety of lebrikizumab in patients with uncontrolled asthma (LAVOLTA I and LAVOLTA II): replicate, phase 3, randomised, double-blind, placebo-controlled trials","year":2016,"lang":"en","type":"article","venue":"The Lancet Respiratory Medicine","topic":"Asthma and respiratory diseases","field":"Medicine","cited_by":466,"is_retracted":false,"has_abstract":false,"ca_institutions":"University Health Network; University of Toronto","funders":"F. Hoffmann-La Roche","keywords":"Medicine; Periostin; Asthma; Placebo; Exacerbation; Internal medicine; Clinical endpoint; Eosinophil; Biomarker; Bronchodilator; Exhaled nitric oxide; Wheeze; Randomized controlled trial; Spirometry; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005065033,0.001900899,0.004978808,0.0005837328,0.0006567129,0.001927269,0.001636523,0.00385326,0.004191819],"category_scores_gemma":[0.004428096,0.00103014,0.006173174,0.0005251276,0.001814458,0.001767396,0.0006568002,0.004207683,0.001122608],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009953399,"about_ca_system_score_gemma":0.001063585,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00127076,"about_ca_topic_score_gemma":0.002145724,"domain_scores_codex":[0.9983278,0.0008199033,0.0001728334,0.0002991493,0.0001582466,0.0002221148],"domain_scores_gemma":[0.997142,0.000968038,0.0008773284,0.000302295,0.0002016704,0.0005085241],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9653018,0.002393505,0.001688818,0.002094425,0.003965168,0.00005726443,0.0001517605,0.0002351503,0.003422915,0.00007324575,0.000873771,0.01974211],"study_design_scores_gemma":[0.9540586,0.04068303,0.002910158,0.00008622422,0.00123067,0.00004046099,0.00002864316,0.0001102212,0.0002846706,0.00008528562,0.0004624855,0.00001949384],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9380618,0.04969376,0.001084118,0.00131697,0.001059191,0.003710038,0.002244194,0.000234797,0.002595194],"genre_scores_gemma":[0.9809568,0.008879759,0.001575099,0.001832278,0.001025464,0.002411812,0.001779399,0.00003737928,0.001501918],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.005065033,"threshold_uncertainty_score":0.0267868,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04440747986722277,"score_gpt":0.3317937343828151,"score_spread":0.2873862545155923,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}